Log in
Enquire now
‌

US Patent 10980741 Compositions and methods for treating pterygium recurrence

Patent 10980741 was granted and assigned to CLOUDBREAK THERAPEUTICS LLC on April, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
Date Filed
December 5, 2018
Date of Patent
April 20, 2021
Patent Applicant
CLOUDBREAK THERAPEUTICS LLC
CLOUDBREAK THERAPEUTICS LLC
Patent Application Number
16210896
Patent Citations
‌
US Patent 10335408 Compositions and methods of using nintedanib for improving glaucoma surgery success
‌
US Patent 10149820 Compositions and methods for treating pterygium
0
‌
US Patent 10688092 Compositions and methods of using nintedanib for improving glaucoma surgery success
0
Patent Citations Received
‌
US Patent 11911379 Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularization
0
Patent Inventor Names
Jinsong Ni
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10980741
Patent Primary Examiner
‌
Theodore R West

Find more entities like US Patent 10980741 Compositions and methods for treating pterygium recurrence

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.